Drug-eluting balloons for treatment of SFA and popliteal disease - A review of current status

Jos C van den Berg

doi:10.1016/j.ejrad.2017.03.015

Drug-eluting balloons for treatment of SFA and popliteal disease - A review of current status

Eur J Radiol. 2017 Jun:91:106-115. doi: 10.1016/j.ejrad.2017.03.015. Epub 2017 Mar 27.

Author

Jos C van den Berg¹

Affiliation

¹ Centro Vascolare Ticino, Ospedale Regionale di Lugano, sede Civico, Via Tesserete 46, 6903 Lugano, Switzerland; Universitätsinstitut für Diagnostische, Interventionelle und Pädiatrische Radiologie, Inselspital, University of Bern, Switzerland. Electronic address: jos.vandenberg@eoc.ch.

PMID: 28629556
DOI: 10.1016/j.ejrad.2017.03.015

Abstract

The endovascular treatment of atherosclerotic disease of the infra-inguinal arteries has changed significantly over the last decades. In an attempt to overcome the high restenosis rates that characterize plain balloon angioplasty and stenting using bare mate stents drug-eluting balloon technology has been applied in the treatment of lesions of the superficial femoral and popliteal artery. This paper will give an overview of the rationale and the technology of drug-eluting balloons and will review currently available data from registries and randomized controlled trials.

Keywords: Balloon angioplasty; Drug-eluting balloon; Peripheral arterial disease; Superficial femoral artery.

Publication types

Review

MeSH terms

Angioplasty, Balloon / instrumentation*
Constriction, Pathologic / physiopathology*
Drug-Eluting Stents / standards*
Femoral Artery / physiology*
Humans
Peripheral Arterial Disease / diagnostic imaging*
Peripheral Arterial Disease / physiopathology*
Peripheral Arterial Disease / therapy
Popliteal Artery / physiopathology*
Randomized Controlled Trials as Topic
Stents
Treatment Outcome